Abstract
Selective rubella vaccination of schoolgirls in Italy started 14 years ago following the United Kingdom strategy that was adopted in 1970. The aims of this program were to eliminate the risk of rubella among women of childbearing age, encourage the acquisition of immunity by natural infection during early childhood and allow the vaccine-induced antibody production by the circulating virus.
On the basis of this program, between 1982 to 1990, a prospective serosurvey for rubella antibody in the province of Pavia was performed.
The results showed a decline in the overall seropositivity rate for rubella antibodies from 57.7% in 1982 to 41.9% in 1984 followed by a remarkable increase in 1985 (53.3%) and in 1987 (56.5%). This trend was confirmed by the number of cases reported to the local Public Health Service. The results of this study provide further evidence of the need to change the current selective immunization policy in order to obtain a significant reduction of risk of the infection in the population.
Similar content being viewed by others
References
BakskiS.S. and CooperL.Z. (1990): Rubella and mumps vaccines - Pediatr. Clin. North Am. 37: 651–668.
BanatvalaJ.E., BestJ.M., 0'SheaS. and DudgeonJ.A. (1985): Persistence of rubella antibodies after vaccination: Detection after experimental challenge -Rev. Infect. Dis. 7: 86–90.
BartKJ., OrensteinW.A., PrebludS.R. and HinmanA.R. (1985): Universal immunization to interrupt rubella - Rev. Infect. Dis. 7: 177–184.
BartS.W., StetlerH.C., PrebludS.R. et al. (1985): Fetal risk associated with rubella vaccine: an update - Rev. Infect. Dis. 7: 95–102.
BerkeleyM.I.K.B., MoffatM.A.J. and RussellD. (1991): Surveillance of antibody to rubella virus in Grampian: closing the immunity gap - Br. Med. J. 303: 1174–1176.
CellesiC., RossoliniA., ZanchiA., GusiM.G., RossoliniG.M. and ValensinP.E. (1989): Immunità umorale virus-specifica dopo vaccinazione antirubeolica - G. Mal. Infett. Parassit. 41: 985–993.
Centers for Disease Control (1991): Increase in rubella and congenital rubella - JAMA 265: 1076–1077.
Centers for Disease Control (1991): Outbreaks of rubella among the Amish-United States, 1991 - MMWR 40: 264–265.
CiammarughiR., RomagnoliG., ZanasiA., MartelliM.T. and ArlottiM. (1989): Prevenzione delta rosolia congenita - G. Mal. Infett. Parassit. 41: 985–993.
CinquettiS., CollaretaA.L. and CasagrandeG. (1989): Epidemiologia delta rosolia: analisi valutativa dell'attuale strategia di vaccinazione - Rivista Italiana di Medicina di Comunità 8: 6–15.
ClarkeM., SeagroattV., SchildG.C., PollockT.M. et al. (1983): Surveys of rubella antibodies in young adults and children - Lancet 26: 667–669.
CochiS.L., EdmondsL.E., DyerK. et al. (1989): Congenital rubella syndrome in the United States, 1970–1985. On the verge of elimination - Am. J. Epidemiol. 129/2: 349–361.
DudgeonJ.A. (1985): Selective immunization: Protection of the individual - Rev. Infect. Dis. 7: 185–190.
EndersG. (1985): Rubella antibody titers in vaccinated and non-vaccinated women and results of vaccination during pregnancy - Rev. Infect. Dis. 7: 103–107.
FureszJ., VarugheseP., AcresS.E. et al. (1985): Rubella immunization strategies in Canada - Rev. Infect. Dis. 7: 191–193.
GalliM.G. (1989): Indagine sulla situazione epidemiologica delta rosolia in Italia a distanza di circa vent'anni dall'introduzione delta vaccinazione -Ann. Ig. 1: 247–254.
GomwalkN.E. and AhmadA. (1985): Prevalence of rubella antibodies on the African continent - Rev. Infect. Dis. 7: 116–121.
GreggN.M. (1941): Congenital cataract following German measles in the mother - Trans. Ophthalmol. Soc. Aust. 3: 35–46.
GudnadòttirM. (1985): Cost-effectiveness of different strategies for prevention of congenital rubella infection: a pratical example from Iceland - Rev. Infect. Dis. 7: 200–209.
HossainA. (1989): Seroepidemiology of rubella in Saudi Arabia - J. Trop. Pediatr. 35: 169–170.
JustM., JustV., BergerR. et al. (1985): Duration of immunity after rubella vaccination: A long-term study in Switzerland - Rev. Infect. Dis. 7: 91–94.
KnoxE.G. (1985): Theoretical aspects of rubella vaccination strategies - Rev. Infect. Dis. 7: 194–197.
KonoR., HirayamaM., SugishitaC. et al. (1985): Epidemiology of rubella and congenital rubella infection in Japan - Rev. Infect. Dis. 7: 56–63.
LeeS.H., EwertD.P., FrederickP.D. and MascolaL. (1992): Resurgence of congenital rubella syndrome in the 1990s. Report on missed opportunities and failed prevention policies among women of childbearing age - JAMA 267: 2616–2620.
MenserM.A., HudsonJ.R., MurphyA.M. and CossartY.E. (1984): Impact of rubella vaccination in Australia- Lancet 12: 1059–1061.
MenserM.A., HudsonJ.R., MurphyA.M. et al. (1985): Epidemiology of congenital rubella and results of rubella vaccination in Australia - Rev. Infect. Dis. 7: 37–41.
MillerC.L., MillerE., WaightP.A. (1987): Rubella susceptibility and the continuing risk of infection in pregnancy - Br. Med. J. 294: 1277–1278.
MingleJ.A.A. (1985): Frequency of rubella antibodies in the population of some tropical african countries -Rev. Infect. Dis. 7: 68–71.
OrensteinW.A., BartK.J., HinmanA.R. (1984): The opportunity and obligation to eliminate rubella from the United States - JAMA 251: 1988–1994.
OrensteinW.A., HerrmannK.L., HolmgreenP. et al. (1986): Prevalence of rubella antibodies in Massachusetts schoolchildren - Am. J. Epid. 124: 290–298.
Pérez-TralleroE., Cilia EguiluzG., Dononsoro IraetaM. and Saenz DominguesJ.R. (1991): Rubella in Guipùzcoa (Basque Country, Spain) a four-year serosurvey - European J. Epidemiol. 4: 183.
RobertsonS.E., CochiS.L., BunnG.A. et al. (1987): Preventing rubella: assessing missed opportunities for immunization - A.J.P.H. 77: 1347–1349.
RobilaroC., FilippoV., ScozzafavaA. et al. (1984): Infezioni virali e gravidanza: la rosolia - Clin. Ter. 110: 265–269.
SchatzmayrH.G. (1985): Aspects of rubella infection in Brazil - Rev. Infect. Dis. 7: 53–55.
SethP., ManjunathN. and BalayaS. (1985): Rubella infection: The indian scene - Rev. Infect. Dis. 7: 64–67.
StanleyF.J., SimM., WilsonG. and WorthingtonS. (1986): The decline in congenital rubella syndrome in Western Australia: an impact of the school girl vaccination program? - A.J.P.H. 76: 35–37.
StewardG.L., ParkmanP.D., NappsH.E., DouglasR.D., HamiltonJ.P., MeyerH.M. (1967): Rubella virus haemoagglutination-inhibition test - New Engl. J. Med. 276: 554.
TobinJ.O'H, SheppardS., SmithellsR.W., MiltonA. et al. (1985): Rubella in the United Kingdom, 1970–1983 -Rev. Infect. Dis. 7: 47–51.
TurnerA. and 0ljugbaO. (1989): Erytema infectiosum in a primary school: investigation of an outbreak in Bury - Public. Health 103: 391–393.
UkkonenP. and von Bonsdorff C.H. (1988): Rubella immunity and morbidity: effects of vaccination in Finland - Scand. J. Infect. Dis. 20: 255–259.
ValensinP.E., GusiM.G. and ZanchiA.et al. (1988): Rubella epidemiology over a 14-year period in Siena (Italy): a retrospective serological survey - Microbiol. 11: 119–127.
WannianS. (1985): Rubella in the People's Republic of China - Rev. Infect. Dis. 7: s72.
WhartonM., CochiS.L. and WilliamsW.W. (1990): Measles, mumps, and rubella vaccines - Infects. Dis. Clin. North. Am. 4: 47–73.
WilsonJ. (1985): Implications of the international initiative against avoidable disablement (“impact”) for rubella control - Rev. Infect. Dis. 7: 198–199.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pelissero, C., Marena, C., Aguzzi, F. et al. Seroepidemiology, morbidity and vaccination strategies against rubella infection. Eight years experience in oltrepo pavese. Eur J Epidemiol 9, 322–326 (1993). https://doi.org/10.1007/BF00146271
Issue Date:
DOI: https://doi.org/10.1007/BF00146271